HUMULIN

This brand name is authorized in United States. It is also authorized in Australia, Brazil, Canada, Croatia, Cyprus, Ecuador, Estonia, Finland, Germany, Hong Kong SAR China, Ireland, Israel, Japan, Lithuania, Malta, New Zealand, Nigeria, Poland, Romania, Singapore, South Africa, Turkey, UK.

Active ingredients

The drug HUMULIN contains one active pharmaceutical ingredient (API):

1	Insulin (human) UNII 1Y17CTI5SR - INSULIN HUMAN
	The blood glucose lowering effect of insulin is due to the facilitated uptake of glucose following binding of insulin to receptors on muscle and fat cells and to the simultaneous inhibition of glucose output from the liver.
	Read more about Insulin (human)

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
HUMULIN I Suspension for injection in a vial	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A10AB01	Insulin (human)	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10A Insulins and analogues → A10AB Insulins and analogues for injection, fast-acting
Discover more medicines within A10AB01
A10AC01	Insulin (human)	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10A Insulins and analogues → A10AC Insulins and analogues for injection, intermediate-acting
Discover more medicines within A10AC01
A10AD01	Insulin (human)	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10A Insulins and analogues → A10AD Insulins and analogues for injection, intermediate-acting combined with fast-acting
Discover more medicines within A10AD01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	1426C, 1531N, 1533Q, 1761Q, 1762R, 1763T
BR	Câmara de Regulação do Mercado de Medicamentos	507601613154412, 507601614150410, 507604502159410, 507604503155419, 507604602153414, 507604603151415
CA	Health Products and Food Branch	00586714, 00587737, 00795879, 01959212, 01959220, 01959239, 02403447, 02415089
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00066789, 00927292, 02406462, 02406479, 02815717, 02817573, 02817604, 02817610, 03382947, 03383912, 03386678, 03386684, 04681882, 04681899, 05917157, 06079072, 06080253, 06577114, 06577120, 07121126, 07121385, 07749801, 07749818, 07759998, 07760004, 09534306, 11540662, 11540679, 12893397, 12893405, 13588839, 13588845, 13978948, 13978954, 16944223, 16944246
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	25.542-01-04, 29355-09-10, 29357-09-10, 29358-09-10
EE	Ravimiamet	1029417, 1115615, 1115637, 1745030, 1745052, 1745074, 1745085
FI	Lääkealan turvallisuus- ja kehittämiskeskus	532390
GB	Medicines & Healthcare Products Regulatory Agency	156032, 175592, 175594, 176087, 176097, 179000, 180490, 196144, 32560, 32643, 32738, 32749, 33114, 33127, 352144, 352145, 374171, 374173, 374200, 374205, 377198, 381396, 381398, 381400, 391006, 396486, 399392
HK	Department of Health Drug Office	26619, 26623, 39494, 39495, 39509, 47649, 62311, 62312
HR	Agencija za lijekove i medicinske proizvode	HR-H-162520244, HR-H-382405435, HR-H-423917539
IE	Health Products Regulatory Authority	69069, 69077, 69100, 69137, 69169, 69183, 69312, 69337
IL	מִשְׂרַד הַבְּרִיאוּת	3317, 3321, 3322, 734, 735
JP	医薬品医療機器総合機構	2492403A3047, 2492403A4051, 2492403H1034, 2492403H4041, 2492403H5030, 2492403H6036, 2492413G9025, 2492413P1024, 2492413P2020
LT	Valstybinė vaistų kontrolės tarnyba	1004375, 1004379, 1004380, 1004381, 1004383, 1076847, 1076848, 1076849, 1076850, 1076851, 1084884, 1084885, 1084886, 1084887, 1084888, 1084889, 1084890
MT	Medicines Authority	MA637/00304, MA637/00305, MA637/00306
NG	Registered Drug Product Database	A6-0149, A6-0270, A6-0271
Switch country to Nigeria in order to find specific presentations of HUMULIN
NZ	Medicines and Medical Devices Safety Authority	3889, 3895, 3900
PL	Rejestru Produktów Leczniczych	100029621, 100091940, 100193970
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W52986002, W52986003, W52999001, W52999002, W52999003, W52999004, W52999005, W53106002, W53106003, W64794001, W64794002, W64794003, W64795001, W64795002, W64795003, W64796001, W64796002, W64796003
SG	Health Sciences Authority	04286P, 04354P, 06019P, 07574P, 07581P, 07684P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699673774206, 8699673774213, 8699673954158, 8699673954165, 8699673954172
US	FDA, National Drug Code	0002-8501, 0002-8824
ZA	Health Products Regulatory Authority	R/21.1/0001, R/21.1/0002